Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Voyager Therapeutics, Inc. (VYGR) had Return on Equity of -13.99% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$15.34M |
|
$-27.43M |
|
-- |
|
$15.34M |
|
$45.27M |
|
$-29.93M |
|
$2.52M |
|
$-27.42M |
|
$-27.42M |
|
$-27.43M |
|
$-27.43M |
|
$-27.43M |
|
$-27.43M |
|
$-29.93M |
|
$-29.41M |
|
58.69M |
|
58.69M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$202.69M |
|
$13.14M |
|
$49.59M |
|
$252.28M |
|
$26.54M |
|
-- |
|
$29.66M |
|
$56.20M |
|
$196.08M |
|
$196.08M |
|
$196.08M |
|
59.05M |
|
| Cash Flow Statement Financials | |
$-132.47M |
|
$125.45M |
|
$0.82M |
|
$74.24M |
|
$68.04M |
|
$-6.21M |
|
$14.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-195.17% |
|
-195.17% |
|
-- |
|
-178.78% |
|
-178.83% |
|
$-135.06M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
8.02 |
|
11.22 |
|
|
Return on Equity |
-13.99% |
-13.99% |
|
-10.87% |
|
-13.99% |
|
$3.32 |
|
$-2.30 |
|
$-2.26 |
|